WisdomTree Extends Limited Duration Stockholder Rights Plan
- None.
- None.
Insights
The extension of a stockholder rights plan, commonly known as a 'poison pill', is a significant defensive tactic used by companies to deter hostile takeovers. By allowing existing shareholders the option to purchase additional shares at a discount upon a triggering event, such as an entity acquiring a significant stake, the plan dilutes the potential acquirer's holdings, making a takeover more expensive and difficult. This strategy can influence the company's stock price and market perception, as it signals the board's intention to maintain control and could potentially discourage investment by those looking to acquire a controlling stake.
From a financial perspective, the rights plan could be seen as a double-edged sword. While it protects current shareholders' interests by preventing undervalued buyouts, it can also be viewed as a deterrent for potential investors or acquirers who might offer a premium for control. This could lead to a stagnation in stock price or even a decrease if the market perceives the move as the company being less open to acquisition opportunities that could have otherwise benefited shareholders. The plan's impact on the company's valuation and market liquidity should be closely monitored by investors.
The unanimous decision by WisdomTree's Board to extend the rights plan is a clear indication of their dedication to corporate governance and the protection of shareholder interests against what they perceive as opportunistic takeover attempts. However, this move also raises questions about the balance between defensive strategies and shareholder rights. While the plan is designed to prevent shareholders from being sidelined in the event of a takeover, it also grants the board substantial power to influence the outcome of such attempts.
The inclusion of a qualifying offer clause that allows shareholders to call a special meeting is a nod to shareholder empowerment, providing a mechanism for them to override the rights plan under specific circumstances. This feature could be seen as a compromise between board authority and shareholder democracy. Investors should consider how this balance affects their rights and the potential for future corporate actions that could impact their investments.
The extension of WisdomTree's rights plan occurs within the broader context of market trends where shareholder activism and takeover attempts are increasingly common. In this environment, a rights plan can be a signal to the market about the company's stance on potential takeovers. It's essential to analyze how similar companies have been affected by the implementation or extension of such plans, as this can provide insights into possible investor reactions and stock performance.
Market participants typically scrutinize such corporate actions for implications on company strategy and growth prospects. If the rights plan is perceived as protective rather than restrictive, it may bolster investor confidence in the board's commitment to enhancing long-term value. Conversely, if the market views the plan as a hindrance to potential value-creating opportunities, it may lead to a less favorable perception of the company's growth trajectory. Thus, the reaction of the stock market to this announcement will be an important indicator of investor sentiment towards WisdomTree's strategic direction.
Stockholders to Vote on Extension of Rights Plan at 2024 Annual Meeting
The rights plan was overwhelmingly approved by the Company’s stockholders at its 2023 Annual Meeting, and the extension of the rights plan reflects the Board’s continued commitment to safeguard the interests of all stockholders in the face of activism concerns, as described in the Board’s response to the most recent demands of WisdomTree stockholder ETFS Capital Limited, and potential opportunistic attempts by a single stockholder or group of stockholders to obtain control of the Company without paying a control premium. The rights plan is designed to ensure that stockholders receive fair and equal treatment in any proposed takeover of the Company and to enable them to realize the long-term value of their investment in WisdomTree.
The rights plan provides several recognized stockholder protections, including the following:
- The rights plan, as amended, will automatically expire on the day after the Company’s 2024 Annual Meeting of Stockholders (“2024 Annual Meeting”), unless approved by stockholders at the 2024 Annual Meeting, in which case it will expire in one year, on March 17, 2025;
-
The rights will be exercisable only if any person (or any persons acting as a group) acquires
10% (or20% in the case of a passive stockholder, i.e., a stockholder that is entitled to file, and files, or has filed with the SEC, a statement on Schedule 13G) or more of the Company’s outstanding common stock; - The rights plan has an exception for offers made for all shares of the Company that treat all stockholders equally, including a qualifying offer clause that provides stockholders the ability to call a special meeting for purposes of exempting a “qualifying offer”;
- The rights plan does not contain any dead-hand, slow-hand, no-hand or similar features that would limit the ability of a future board of directors to redeem the rights; and
- The rights plan does not preclude the Board from considering an offer that recognizes the full value of the Company.
Additional Information on Stockholder Rights Plan
Initially, the rights are not exercisable and trade with the shares of WisdomTree common stock and Series A Preferred Stock. The rights generally will become exercisable if a person or group becomes an “acquiring person” by acquiring
A person or group who beneficially owned
The rights plan, as amended, will expire on the day after the 2024 Annual Meeting, unless approved by stockholders at the 2024 Annual Meeting, in which case it will expire in one year, on March 17, 2025. The date of the 2024 Annual Meeting has not yet been announced. The rights plan contains a qualifying offer clause that provides stockholders the ability to call a special meeting for purposes of exempting a “qualifying offer.” Further details about the rights plan are contained in Current Reports on Form 8-K and in a Registration Statement on Form 8-A and amendments thereto that WisdomTree has filed or will file with the
Advisors
BofA Securities is serving as financial advisor, and Paul Hastings LLP is serving as legal counsel to WisdomTree. Innisfree M&A is serving as proxy solicitor and H/Advisors Abernathy is serving as strategic communications advisor.
About WisdomTree
WisdomTree is a global financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models, solutions and products leveraging blockchain-enabled technology. We empower investors and consumers to shape their future and support financial professionals to better serve their clients and grow their businesses. WisdomTree is leveraging the latest financial infrastructure to create products that provide access, transparency and an enhanced user experience. Building on our heritage of innovation, we are also developing and have launched next-generation digital products, services and structures, including digital or blockchain-enabled mutual funds and tokenized assets, as well as our blockchain-native digital wallet, WisdomTree Prime™.*
*The WisdomTree Prime digital wallet and digital asset services are made available through WisdomTree Digital Movement, Inc. (NMLS ID: 2372500) in select
WisdomTree currently has approximately
For more information about WisdomTree and WisdomTree Prime™, visit: https://www.wisdomtree.com.
Please visit us on X, formerly known as Twitter, at @WisdomTreeNews.
WisdomTree® is the marketing name for WisdomTree, Inc. and its subsidiaries worldwide.
Cautionary Statement Regarding Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including statements regarding the anticipated benefits and expected consequences of the rights plan, as amended, that WisdomTree has adopted. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated, including, but not limited to, the effectiveness of the rights plan in providing the Board of Directors with time to make informed decisions that are in the best long-term interests of WisdomTree and its stockholders, and other risk factors discussed from time to time in its filings with the SEC, including those factors discussed under the caption “Risk Factors” in its most recent annual report on Form 10-K, filed with the SEC on February 23, 2024, and in subsequent reports filed with or furnished to the SEC. WisdomTree assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
Category: Business Update
View source version on businesswire.com: https://www.businesswire.com/news/home/20240318731305/en/
Investor Relations
WisdomTree, Inc.
Jeremy Campbell
+1.646.522.2602
Jeremy.Campbell@wisdomtree.com
or
Innisfree M&A Incorporated
Scott Winter / Jonathan Salzberger
+1.212.750.5833
swinter@innisfreema.com / jsalzberger@innisfreema.com
Media Relations
WisdomTree, Inc.
Jessica Zaloom
+1.917.267.3735
jzaloom@wisdomtree.com / wisdomtree@fullyvested.com
or
H/Advisors Abernathy
Tom Johnson / Dana Gorman
+1.212.371.5999
tom.johnson@h-advisors.global / dana.gorman@h-advisors.global
Source: WisdomTree, Inc.
FAQ
What is the purpose of extending WisdomTree's stockholder rights plan?
When will the rights plan expire if not approved by stockholders at the 2024 Annual Meeting?
What triggers the rights plan to become exercisable?
What happens if WisdomTree is acquired in a merger or business combination?